Karimah Es Sabar

CEO and Partner
Quark Venture LP

Karimah Es Sabar is the founding CEO and partner of global venture capital firm Quark Venture LP, chair of Canada’s Health and Biosciences Economic Strategy Table and board chair of Triumf Innovations. Previously, she was president and CEO of the Centre for Drug Research and Development and Life Sciences BC.

WHAT’S NEW: Quark Venture and the Global Health Sciences Fund now have 28 active portfolio companies from Canada, the U.S., Israel and Europe.
EDUCATION: Master of science in neurochemistry from the University of London.
GREATEST SUCCESS: Global project management and launch of the world’s first Haemophilus influenzae type B vaccine.

"HOMETOWN: Nairobi, Kenya. BEST HABIT: “I love connecting people – the constant connector – it is all about human connection, I believe.” FUN FACT: “I fenced at university competitively and was on my university fencing team.”"